Results 241 to 250 of about 57,705 (278)

Effects of a Multimodal Program on Frailty Syndrome and Psychological Alterations in Breast Cancer Women Treated with Aromatase Inhibitors. [PDF]

Clin Pract
Céspedes P, Martínez-Arnau FM, Torregrosa MD, Cauli O, Buigues C.   +4 more
europepmc   +1 more source

Systematic literature review and trial-level meta-analysis of aromatase inhibitors vs tamoxifen in patients with HR+/HER2- early breast cancer. [PDF]

Breast
Janni W, Untch M, Harbeck N, Gligorov J, Jacot W, Chia S, Boileau JF, Gupta S, Mishra N, Akdere M, Danyliv A, Curigliano G.   +11 more
europepmc   +1 more source

Correction to: "The Combination of Aromatase Inhibitors and GH Treatment for Idiopathic Short Stature in Male Adolescents".

J Clin Endocrinol Metab
europepmc   +1 more source

Synthesis, Characterization, and <i>In Vitro</i> and <i>In Silico</i> Studies of New Triazole Derivatives as Aromatase Inhibitors. [PDF]

Med Chem
Uzmez ZL, Osmaniye D, Ozkay Y, Kaplancıklı ZA.   +3 more
europepmc   +1 more source

Nanoemulsion-based transdermal delivery of third-generation steroidal and non-steroidal aromatase inhibitors in preclinical models. [PDF]

Cell Prolif
Gao L, Gao L, Huang S, Sun L, Li M, Shen C, Chen Y, Tan R, Chen Y, Zhan C, Wieland FH, Liu Y, Zhang Y, Luo Y.   +13 more
europepmc   +1 more source

New Promising Steroidal Aromatase Inhibitors with Multi-Target Action on Estrogen and Androgen Receptors for Breast Cancer Treatment. [PDF]

Cancers (Basel)
Amaral C, Almeida CF, Valente MJ, Varela CL, Costa SC, Roleira FMF, Tavares-da-Silva E, Vinggaard AM, Teixeira N, Correia-da-Silva G.   +9 more
europepmc   +1 more source

Pharmacophore-based virtual screening, molecular docking, and molecular dynamics investigation for the identification of novel, marine aromatase inhibitors. [PDF]

BMC Chem
Kotb MA, Abdelmawgood IA, Ibrahim IM.
europepmc   +1 more source

Palbociclib plus aromatase inhibitors in patients with metastatic breast cancer and cardiovascular diseases: real-world effectiveness. [PDF]

Oncologist
Brufsky A, Liu X, Li B, McRoy L, Chen C, Makari D, Layman RM, Rugo HS.   +7 more
europepmc   +1 more source

Efficacy, Safety, and Biomarkers of Neoadjuvant Dalpiciclib (CDK4/6 inhibitor) plus Aromatase Inhibitors in Operable HER2-Negative Luminal B Breast Cancer: A Prospective, Single-Center, Single-Arm, Phase II Trial (DANCER). [PDF]

MedComm (2020)
Zhou Y, Zhang Z, Chen H, Huang F, Shen L, Tao S, Qian W, Hong H, Pan C, Wang Z, Zhang J, Hu Y, Shen Y, Fu J, Mao W, Wu S, Guo X, Wang H, Ma M, Ma T, Pan L, Chen Y.   +21 more
europepmc   +1 more source

Adverse Drug Event-based Stratification of Tumor Mutations: A Case Study of Breast Cancer Patients Receiving Aromatase Inhibitors.

, 2014
Chen Wang, Michael T. Zimmermann, Naresh Prodduturi, Christopher G. Chute, Guoqian Jiang   +4 more
openalex   +1 more source